Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,340,545
+$152,165 QoQ
Shares Held
14,748
+0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#802
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. AMGN ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
This page
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,340,545 | 14,748 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,188,380 | 14,746 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $5,164,297 | 15,778 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,456,784 | 15,793 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $4,878,636 | 17,473 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $5,479,541 | 17,588 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $4,573,710 | 17,548 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $5,836,834 | 18,115 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,750,642 | 18,405 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,321,048 | 18,715 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $5,412,183 | 18,791 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $5,058,331 | 18,821 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $4,198,398 | 18,910 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,587,206 | 18,975 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,064,224 | 19,282 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $4,266,145 | 18,927 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $4,603,722 | 18,922 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,582,972 | 18,952 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,390,064 | 19,514 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,137,105 | 19,455 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,715,343 | 19,345 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,813,229 | 19,345 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,474,243 | 19,460 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,897,409 | 19,269 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,588,656 | 19,455 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,906,404 | 19,269 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||